GM Drops 8% Post-Earnings as Analysts Slash Targets

GM just reported its Q3 results and the market's response has been brutal: the stock fell 6.8% on Tuesday and is down 8.2% on the week, closing at $77.09. The question now is whether the analyst community's still-bullish consensus reflects genuine conviction or simply hasn't caught up.

The target-cutting on the Street has been swift and broad. Six firms lowered their price objectives on the day of the print alone. Goldman Sachs cut from $112 to $96, keeping its Buy rating. Morgan Stanley trimmed from $101 to $95, holding Overweight. Barclays moved from $110 to $105, also Overweight. UBS dropped from $112 to $109, retaining Buy. The pattern is uniform: maintained positive ratings, meaningfully lower numbers. TD Cowen was the exception, reiterating Buy with a $132 target unchanged. JP Morgan had already trimmed to $110 from $120 on October 12 ahead of the print. The consensus mean now stands at $101.22, still implying more than 30% upside to the current price. That gap is notable. It either signals that the Street sees the selloff as an overreaction, or that more target revisions are still coming.

The bear case rests on a deteriorating cost picture: roughly $1.15 billion in higher commodity and DRAM inflation, plus $850 million in US onshoring costs, headwinds that are outpacing the savings from EV rightsizing and warranty improvements. The bull case points to GM's raised 2026 adjusted EBIT guidance of $14 billion to $16 billion, its 17.4% US market share, and high-margin businesses including OnStar, GM Defense, and energy storage that could eventually support a multiple re-rating. The PE has compressed to 5.2x, and at 0.94x book, the stock trades below net asset value. The EV/EBITDA of 7.1x, down from around 7.5x a month ago, reflects the price decline rather than any fundamental deterioration. Factor positioning adds nuance: the 12-month forward EPS growth rank is in the 91st percentile, and the days-to-cover rank is in the 82nd, meaning short sellers would need considerable time to exit at current volumes. Yet the EV/EBIT score ranks in just the 29th percentile, which points to lingering valuation concerns on an operating-income basis.

One differentiated data point cuts against the bearish read on the quarter. KBA new car registrations in Germany, published by the Kraftfahrt-Bundesamt and measured by ORTEX to lead GM's quarterly revenue by 15 days with a strong fit across 18 quarters, ran 133% above the same quarter last year across the full July-to-September window, all three months in. That is not a forecast, but it does indicate a sharp year-on-year improvement in German volumes for the period GM just reported. Wikipedia traffic for GM is also running at an unusually elevated level relative to its own 90-day history, with a z-score of 2.6, reflecting the post-earnings retail attention surge.

Short interest is low and lending conditions are undisturbed. GM's SI % of free float is 2.3%, up about 7% on the week as a small number of new shorts entered the borrow market after the earnings drop, but that is a minor, routine move. Borrow availability remains effectively unlimited, and the cost to borrow is 0.33%. There is no squeeze dynamic. Options positioning has shifted slightly more defensive: the put/call ratio rose to 0.76, about 1.75 standard deviations above its 20-day mean of 0.71, the highest reading since late September. That is elevated but not extreme, sitting well below the 52-week high of 1.10. The options market has hedged a little more aggressively than usual, but there is no sign of panic buying.

The setup going forward is less about whether GM can execute on the bull case and more about whether the cost headwinds from commodities and onshoring prove sticky or transitory. The next earnings event is scheduled for late January 2027, giving the company a full quarter to demonstrate whether the raised EBIT guidance holds against rising input costs.